5 September 2017
Personalized treatments for cancer are multiplying. As they multiply, so do clinical questions, such as: Which targeted therapies will be most effective? Have the first signs of a relapse begun? When does a tumor become resistant to the current protocol? In this video, discover how Droplet Digital PCR technology, which can be utilized for the absolute quantification of nucleic acids, is being utilized for clinical applications.